Spain, June 25 -- Spain based JANSSEN-CILAG, S.A. has secured contract from Gerencia de Atencion Especializada de Salamanca for Various Medicinal Products - Supply of the drug whose active substance is Daratumumab for the University Assistance Complex of Salamanca. The value of the contract is worth 163613100 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....